ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 78 filers reported holding ADICET BIO INC in Q4 2023. The put-call ratio across all filers is 10.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,830,246 | +74149.3% | 1,512,600 | +44.2% | 0.00% | -25.0% |
| Q1 2024 | $2,465 | +70.1% | 1,049,000 | +36.8% | 0.00% | +100.0% |
| Q4 2023 | $1,449 | +56.3% | 766,600 | +13.2% | 0.00% | 0.0% |
| Q3 2023 | $927 | +81.4% | 677,000 | +221.8% | 0.00% | +100.0% |
| Q2 2023 | $511 | -71.9% | 210,403 | -33.4% | 0.00% | -50.0% |
| Q1 2023 | $1,819 | +583.8% | 315,800 | +963.3% | 0.00% | – |
| Q4 2022 | $266 | -100.0% | 29,700 | -76.3% | 0.00% | -100.0% |
| Q2 2022 | $1,832,000 | +453.5% | 125,500 | +197.3% | 0.00% | – |
| Q3 2021 | $331,000 | -60.6% | 42,217 | -48.3% | 0.00% | -100.0% |
| Q2 2021 | $841,000 | +219.8% | 81,700 | +306.5% | 0.00% | – |
| Q1 2021 | $263,000 | – | 20,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $42,160,000 | 11.96% |
| Foresite Capital Management V, LLC | 680,000 | $13,580,000 | 5.55% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $3,395,000 | 4.75% |
| Tri Locum Partners LP | 523,256 | $10,449,000 | 4.08% |
| DAFNA Capital Management LLC | 715,872 | $14,296,000 | 3.72% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $11,583,000 | 3.55% |
| COWEN AND COMPANY, LLC | 1,500,055 | $29,956,000 | 2.88% |
| JOHNSON & JOHNSON | 728,944 | $14,557,000 | 2.75% |
| Orbimed Advisors | 7,447,141 | $148,719,000 | 2.41% |
| Ikarian Capital, LLC | 507,348 | $10,132,000 | 1.33% |